2Jones MB, Krutzsch H, Shu H, et al. Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer[J]. Proteomics, 2002, 2(1) :76-84.
3Emmert-Buck MR, Gillespie JW, Paweletz CP, et al. An approach to proteomic analysis of human tumors[J]. Mol Carcinog, 2000, 27(3):158-165.
4Zhou G, Li H, DeCamp D, et al. 2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers[J]. Mol Cell Proteomics, 2002,1(2):117-124.
5Greengauz-Roberts O, Stoppler H, Nomura S, et al. Saturation labeling with cysteine-reactive cyanine fluorescent dyes provides increased sensitivity for protein expression profiling of laser-microdissected clinical specimens[J] . Proteomics,2005,5(7): 1746-1757.
6Tian Q, Stepaniants SB, Mao M, et al. Integrated genomic and proteomic analyses of gene expression in mammalian cells[J]. Mol Cell Proteomics,2004,3(10) :960-969.
7Yan W, Lee H, Yi EC, et al. System-based proteomic analysis of the interferon response in human liver cells [ J ]. Genome Biol, 2004,5 ( 8 ):R54.
8Tam EM, Morrison CJ, Wu YI, et al. Membrane protease proteomics:Isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates [ J ]. Proc Natl Acad Sci USA, 2004, 101(18) :6917-6922.
9Petricoin EF, Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer[ J ]. Lancet, 2002,359 (9306): 572-577.
10Petricoin EF, Liotta LA. SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer[J]. Curr Opin Biotechnol, 2004, 15(1) :24-30.
二级参考文献21
1Anderson N. Proteome and proteomics: new technologies, newconcepts, and new words [J]. Electrophoresis, 1998, 19:1853 -1861.
2O'Parrell PH. High resolution two-dimensional electrophoresis of proteins [J]. Journal of Biological Chemistry, 1975, 250:4007 -4021.
3Aebersold R, Mann M. Mass spectrometry-based proteomics [J].Nature, 2003, 422:198 - 207.
5Pandey A, Mann M. Proteomics to study genes and genomes [J].Nature, 2000, 405:837 - 846.
6Jungblut PR, Zimny AU, Zeindl EE, et al. Proteomics in human disease: cancer, heart and infectious diseases [J]. Electrophoresis,1999, 20(10): 2100-2110.
7Celis J, Wolf H, Ostergaard M. Bladder squamous cell carcinoma biomarkers derived from proteomics [J] . Electrophoresis, 2000,21(11): 2115 -2121.
8Sarto C, Frutiger S, Cappellano F, et al. Modified expression of plasma glutathione peroxidase and manganese superoxide dismutase in human renal cell carcinoma [J]. Electrophoresis,1999,20( 17): 3458 - 3466.
9Seliger B, Kellner R. Design of proteome-based studies in combination with serology for the identification of biomarkers and novel targets [J]. Proteomies, 2002, 2( 12): 1645 - 1651.
10Kellner S, Lichtenfels R, Atkins D, et al.Targeting of tumor associated antigens in renal cell carcinoma using proteome-based analysis and their clinical significance [J] . Proteomics, 2002, 2(12): 1743 - 1751.
